Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Exxon Mobil Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Exxon Mobil Corporation trades at $178.39 (market cap $727.85B). The key difference: Exxon Mobil Corporation is far larger — about 23.5× GE HealthCare Technologies Inc. Common Stock's market cap, and Exxon Mobil Corporation pays the higher dividend (2.33%). Which is the better fit depends on your goals.
| GEHC | XOM | |
|---|---|---|
Market Cap | $30.93B | $727.85B |
Volume | 5,033,451 | 10,493,203 |
Sector | Health | Energy |
52-Week High | $88.16 | $177.06 |
52-Week Low | $59.48 | $110.64 |
Enterprise Value | $39.39B | $759.63B |
Dividend Yield | 0.23% | 2.33% |
Typical Hold Time | — | 100 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
ExxonMobil (XOM) trades at $174.13, up 1.15% with a bullish technical signal from moving averages. The company maintains strong profitability with 9.07% net margin and 12.55% ROE, though revenue declined to $323.91B in 2025. Recent developments include negotiations to return to Venezuela's oil fields and expansion in Guyana and Permian Basin assets targeting 5.5 MMBoe/d production by 2030.
XOM presents a mixed outlook with analyst consensus at Hold (56.37%) and $166.67 price target below current levels. Upside potential exists from strategic expansions and LNG market growth, but risks include declining revenue trends, geopolitical exposure in Venezuela, and refinery operational challenges. The stock trades near resistance at $174 with RSI indicating overbought conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
